OSIRIS THERAPEUTICS, INC. 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Jun 13, 2016

Insider Transaction Report

Form 4

Period: 2016-06-09

OSIRIS THERAPEUTICS, INC.OSIR

Montgomery Bobby Dwayne

Chief Business Officer

Transactions

Disposition to Issuer
Incentive Stock Options (right to buy)
2016-06-09$12.39/sh+6,250$77,438→ 35,000 total
Exercise: $12.39From: 2018-04-21Exp: 2024-04-21→ Common Stock (6,250 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$18.40/sh+3,125$57,500→ 28,750 total
Exercise: $18.40From: 2018-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$12.39/sh+6,250$77,438→ 41,250 total
Exercise: $12.39From: 2017-04-21Exp: 2024-04-21→ Common Stock (6,250 underlying)
Disposition to Issuer
Incentive Stock Options (right to buy)
2016-06-09$18.40/sh+3,125$57,500→ 31,875 total
Exercise: $18.40From: 2017-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$7.39/sh+2,500$18,475→ 23,125 total
Exercise: $7.39From: 2017-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$7.39/sh+2,500$18,475→ 20,625 total
Exercise: $7.39From: 2018-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$7.39/sh+2,500$18,475→ 18,125 total
Exercise: $7.39From: 2019-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$7.39/sh+2,500$18,475→ 15,625 total
Exercise: $7.39From: 2020-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2016-06-09$18.40/sh+3,125$57,500→ 25,625 total
Exercise: $18.40From: 2019-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)

Footnotes (1)

[F1]Unvested incentive stock options that were forfeited concurrent with the Reporting Person's separation from the company, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he separated from the company will remain exercisable for 90 days from the departure date.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -